“…However, this is not surprising, as similar psychopathology across psychiatric conditions is likely to share neuropathogenic mechanisms (Insel et al, 2010). In this vein, it is interesting to consider systemic inflammation as a mediating link between anhedonia and diminished prefrontal activity across psychiatric conditions (Bauer & Teixeira, 2019;Freed et al, 2018;Stanton, Holmes, Chang, & Joormann, 2019). In this regard, anti-inflammatory treatment might be promising in treating anhedonia in some PTSD patients, as preliminary studies have shown it to be efficient in treating subgroups of patients with depression and schizophrenia (Khandaker et al, 2015;Miller & Raison, 2016).…”